Frazier Healthcare Partners

Frazier Healthcare Partners, established in 1991, is a prominent healthcare investment firm with headquarters in Seattle, Washington, and an additional office in Menlo Park, California. The firm is dedicated to providing growth and buyout capital to companies across various sub-sectors within the healthcare industry. With a long-standing history, Frazier has successfully raised over $7.1 billion in capital, solidifying its position as a significant player in healthcare private equity.

The firm operates through two distinct investment strategies: Growth Buyout and Venture. The Growth Buyout strategy focuses on partnering with profitable healthcare services, pharmaceutical services, and medical products companies. For these investments, Frazier typically commits equity checks ranging from $50 million to $300 million, targeting established businesses with strong growth potential and proven business models. This approach emphasizes operational improvements and strategic expansion to drive value creation.

In parallel, Frazier's Venture strategy targets earlier-stage opportunities, primarily within the biopharmaceutical and medical device sectors. This arm of the firm seeks out innovative companies with groundbreaking technologies or therapies that have the potential to significantly impact patient care. Venture investments typically involve equity commitments between $10 million and $50 million, supporting companies through their critical development phases, including clinical trials and commercialization efforts. This dual-strategy approach allows Frazier Healthcare Partners to engage with companies across different stages of their lifecycle, from nascent startups to mature enterprises, all within the dynamic healthcare ecosystem.